Published in Br J Haematol on February 01, 2000
Phase I study to determine the safety, tolerability and immunostimulatory activity of thalidomide analogue CC-5013 in patients with metastatic malignant melanoma and other advanced cancers. Br J Cancer (2004) 1.43
Continuous low-dose dexamethasone in relapsed or refractory multiple myeloma. Br J Haematol (2000) 1.07
Bypass of tumor drug resistance by antivascular therapy. Neoplasia (2004) 0.86
Current and emerging treatment options for patients with relapsed myeloma. Clin Med Insights Oncol (2013) 0.86
Thalidomide therapy in refractory solid tumour patients. Br J Haematol (2000) 0.85
Differential effects of thalidomide on angiogenesis and tumor growth in mice. Inflammation (2001) 0.81
An evaluation of factors predicting long-term response to thalidomide in 234 patients with relapsed or resistant multiple myeloma. Br J Cancer (2004) 0.81
Therapy strategies for multiple myeloma: current status. Wien Klin Wochenschr (2003) 0.81
Lovastatin and thalidomide have a combined effect on the rate of multiple myeloma cell apoptosis in short term cell cultures. Eur J Clin Pharmacol (2006) 0.77
Sternal fractures: a red flag or a red herring? J Trauma (1994) 2.16
Allogeneic hematopoietic stem-cell transplantation in AML and MDS using myeloablative versus reduced-intensity conditioning: the role of dose intensity. Leukemia (2006) 2.04
Ongoing HIV dissemination during HAART. Nat Med (1999) 1.85
Prophylaxis regimens for GVHD: systematic review and meta-analysis. Bone Marrow Transplant (2008) 1.63
Evaluation of the appropriateness of blood and blood product transfusion using preset criteria. Transfusion (1989) 1.57
Genetic basis of hemolytic anemia caused by pyrimidine 5' nucleotidase deficiency. Blood (2001) 1.52
Gene expression profiles of AML derived stem cells; similarity to hematopoietic stem cells. Leukemia (2006) 1.50
Genotypic variation of HIV-1 reverse transcriptase and protease: comparative analysis of clade C and clade B. AIDS (2001) 1.48
Clomiphene as a novel modality for the treatment of acute myeloid leukemia: A pilot phase II study. Leuk Res (2011) 1.40
Severe hypophosphataemia in autograft recipients during accelerated leucocyte recovery. Br J Haematol (1995) 1.39
Transient normal platelet counts and decreased requirement for interferon during pregnancy in essential thrombocythaemia. Br J Haematol (1996) 1.39
Recurrent bilateral parotitis in acute myeloid leukemia. Acta Haematol (1991) 1.39
Rheumatic manifestations preceding adult acute leukemia: characteristics and implication in course and prognosis. Acta Haematol (1999) 1.18
Antibody response to a two-dose regimen of influenza vaccine in allogeneic T cell-depleted and autologous BMT recipients. Bone Marrow Transplant (1993) 1.17
Is CT scan still necessary for staging in Hodgkin and non-Hodgkin lymphoma patients in the PET/CT era? Ann Oncol (2005) 1.12
Acute promyelocytic leukaemia with t(15;17) following treatment of Hodgkin's disease--a report of 4 cases. Ann Oncol (1995) 1.09
Characteristics of candidaemia with Candida-albicans compared with non-albicans Candida species and predictors of mortality. J Hosp Infect (2005) 1.08
Allogeneic hematopoietic stem-cell transplantation in AML and MDS using myeloablative versus reduced-intensity conditioning: long-term follow-up. Leukemia (2010) 1.08
Drug-induced erythrocyte membrane internalization. J Clin Invest (1972) 1.08
A family with three beta-delta-thalassemia homozygotes. Blood (1970) 1.06
Extramedullary disease and targeted therapies for hematological malignancies--is the association real? Ann Oncol (2006) 1.02
Imatinib mesylate (STI571) in preparation for allogeneic hematopoietic stem cell transplantation and donor lymphocyte infusions in patients with Philadelphia-positive acute leukemias. Leukemia (2003) 1.01
Sudden onset deafness as a presenting manifestation of chronic lymphocytic leukemia. Leuk Lymphoma (1993) 0.97
A family with red cell pyrimidine 5'-nucleotidase deficiency. Blood (1976) 0.97
Successful treatment of disseminated Mycobacterium simiae infection in AIDS patients. Scand J Infect Dis (1998) 0.96
Extramedullary hematopoiesis with multiple tumor-simulating mediastinal masses in a patient with beta-thalassemia intermedia. Isr J Med Sci (1977) 0.95
Thoracoscopic upper thoracic sympathectomy for primary palmar hyperhidrosis--the combined paediatric, adolescents and adult experience. Eur J Surg Suppl (1998) 0.94
Outcome and prognostic factors in advanced Hodgkin's disease treated with high-dose chemotherapy and autologous stem cell transplantation: a study of 341 patients. Ann Oncol (2004) 0.94
Two cycles of escalated BEACOPP followed by four cycles of ABVD utilizing early-interim PET/CT scan is an effective regimen for advanced high-risk Hodgkin's lymphoma. Ann Oncol (2009) 0.93
IL-2 induces T cell adherence to extracellular matrix: inhibition of adherence and migration by IL-2 peptides generated by leukocyte elastase. J Immunol (1998) 0.93
Transformation of chronic lymphocytic leukemia to plasmacytoma. Cancer (1984) 0.92
Human Exserohilum and Bipolaris infections: report of Exserohilum nasal infection in a neutropenic patient with acute leukemia and review of the literature. J Med Vet Mycol (1987) 0.92
Diffuse alveolar hemorrhage in acute promyelocytic leukemia patients treated with ATRA--a manifestation of the basic disease or the treatment. Leuk Lymphoma (2000) 0.92
Ibritumomab tiuxetan (Zevalin) combined with reduced-intensity conditioning and allogeneic stem-cell transplantation (SCT) in patients with chemorefractory non-Hodgkin's lymphoma. Bone Marrow Transplant (2007) 0.91
Prevention of the respiratory distress syndrome in premature infants by antepartum glucocorticoid therapy. Br J Obstet Gynaecol (1976) 0.90
VB-201, an oxidized phospholipid small molecule, inhibits CD14- and Toll-like receptor-2-dependent innate cell activation and constrains atherosclerosis. Clin Exp Immunol (2014) 0.89
Molecular analysis of Burkitt's leukemia in two hemophilic brothers with AIDS. Blood (1987) 0.89
Chimerism testing and detection of minimal residual disease after allogeneic hematopoietic transplantation using the bioView (Duet) combined morphological and cytogenetical analysis. Leukemia (2002) 0.89
Waldenström's hyperglobulinemic purpura: an unusual immune complex disorder. Clin Rheumatol (1984) 0.88
Demonstration of clonable alloreactive host T cells in a primate model for bone marrow transplantation. Proc Natl Acad Sci U S A (1986) 0.88
Respiratory failure and intensive care treatment in bone marrow-transplanted patients. Intensive Care Med (1996) 0.88
Spurious haemoglobinopathy. Lancet (1986) 0.87
Evaluation of sickle hemoglobin and desickling agents by falling ball viscometry. J Lab Clin Med (1972) 0.87
Plasma cell leukemia with IgD paraprotein. Arch Intern Med (1968) 0.87
Colon carcinoma in the adolescent. Pediatr Surg Int (1997) 0.86
Fluidity difference of membrane lipids in human normal and leukemic lymphocytes as controlled by serum components. Cancer Res (1977) 0.86
Hyperglycemia during acute myocardial infarction. A six-year follow-up study. JAMA (1975) 0.86
Tetraploid myeloid cells in donors of peripheral blood stem cells treated with rhG-CSF. Bone Marrow Transplant (2003) 0.86
VDAC1-based peptides: novel pro-apoptotic agents and potential therapeutics for B-cell chronic lymphocytic leukemia. Cell Death Dis (2013) 0.84
Calcification in untreated non-Hodgkin's mediastinal lymphoma. South Med J (1998) 0.84
The hypereosinophilic syndrome associated with CD4+CD3- helper type 2 (Th2) lymphocytes. Leuk Lymphoma (2001) 0.84
Evaluation of an intervention aimed at reducing inappropriate use of preoperative blood coagulation tests. Arch Intern Med (1989) 0.83
Secondary malignancies after allogeneic stem-cell transplantation in the era of reduced-intensity conditioning; the incidence is not reduced. Leukemia (2012) 0.83
Erythrocyte membrane vacuole formation in hereditary spherocytosis. Br J Haematol (1974) 0.83
Disseminated visceral fusariosis treated with amphotericin B-phospholipid complex. Leuk Lymphoma (1993) 0.83
Selective vitamin B 12 malabsorption with proteinuria in Israel: clinical and genetic aspects. Isr J Med Sci (1969) 0.83
Remission of malabsorption in congenital intestinal lymphangiectasia following chemotherapy for lymphoma. Leuk Lymphoma (1993) 0.82
Gene analysis in delta beta and delta (0) thalassemia. J Biol Chem (1984) 0.82
Congenital haemolytic anaemia associated with adenylate kinase deficiency. Br J Haematol (1994) 0.82
A search for bcl1, bcl2, and c-myc oncogene rearrangements in chronic lymphocytic leukemia. Leukemia (1989) 0.82
Detection of minimal residual disease in acute myelogenous leukemia. Acta Haematol (2004) 0.81
Engraftment-associated hypophosphatemia--the role of cytokine release and steep leukocyte rise post stem cell transplantation. Bone Marrow Transplant (2001) 0.81
Translocation (2;14)(p13;q32) in CD10+ ;CD13+ acute lymphatic leukemia. Cancer Genet Cytogenet (1995) 0.81
Graft-versus-leukemia in chronic lymphocytic leukemia. Bone Marrow Transplant (2007) 0.81
Sequestration studies with chromium-51 labeled red cells as criteria for splenectomy. Isr J Med Sci (1968) 0.81
Extramedullary progression despite a good response in the bone marrow in patients treated with thalidomide for multiple myeloma. Leuk Lymphoma (2001) 0.81
Immune response to polio vaccination in bone marrow transplant recipients. Bone Marrow Transplant (1991) 0.80
Linkage analysis for major histocompatibility complex-related genetic susceptibility in familial chronic lymphocytic leukemia. Blood (2000) 0.80
Acute leukemia relapse presenting as central diabetes insipidus. Cancer (1994) 0.80
Hepatic telangiectases and portosystemic encephalopathy in Osler-Weber-Rendu disease. Gastroenterology (1968) 0.80
Globin synthesis in iron-deficiency anemia. Blood (1974) 0.80
Hybrid acute leukemia. Leuk Res (1984) 0.80
Parenteral administration of an activating monoclonal antibody to the alpha1beta1 integrin in dogs. Immunobiology (2000) 0.79
T-cell acute lymphoblastic leukemia with severe leukopenia: evidence for suppression of myeloid progenitor cells by leukemic blasts. Acta Haematol (1988) 0.79
Bromobenzene accelerates hepatocyte streaming in rats. Gastroenterology (1992) 0.79
Thrombotic thrombocytopenic purpura complicating chronic myelogenous leukemia treated with interferon-alpha. A report of two successfully treated patients. Acta Haematol (1998) 0.79